NEWS: JUNE 2005

-06/28/2005-

Press Release: Moritex have announced the launch of Clarity™ - a complete spectroscopic imaging and client management system for medical spas, dermatologists and skin care specialists. To read press release click here.

-06/24/2005-

Genentech Inc. buys manufacturing plant from Biogen Idec. To read article click here.

Gilead Sciences Inc. to end Tamiflu agreement with Roche. To read article click here.

FDA approves UCB Pharma Inc.'s drug Keppra® (levetiracetam) to treat epilepsy in children. To read article click here.

Telik Inc. to give company updates at the Bear Stearns Biotechnology Conference in Cambridge, MA on
Tuesday, June 28, 2005. To read article click here.

-06/23/2005-

Edwards Lifesciences Corporation initiates Phase I clinical trials of EW-A-401 for limb ischemia treatment. To read article click here.

FDA approves NitroMed Inc.'s BiDil® (isosorbide dinitrate/hydralazine hydrochloride) for the treatment of heart failure in black patients. To read article click here.

ChemDiv Inc. and AdipoGenix Inc. extend drug discovery collaboration on obesity and type 2 diabetes. To read article click here.

Arena Pharmaceuticals begins Phase IIb clinical trials of APD356 for obesity treatment. To read article click here.

FDA approves Boehringer Ingelheim Pharmaceuticals Inc.'s Aptivus® (tipranavir) for HIV treatment. To read article click here.

Dynavax Technologies Corp. begins Phase III clinical trials of Engerix-B® vaccine for hepatitis B treatment. To read article click here.

-06/22/2005-

Press Release: Using a range of scientific equipment supplied by Radleys the development kitchen at the world renowned Fat Duck Restaurant (Bray, UK) is undertaking research to produce novel food textures and innovative food for high-end gastronomy. To read press release click here.

Peregrine Pharmaceuticals Inc. announces its antibody therapy Tarvacin binds to at least six different virus families inhibiting virus repilcation or tumor growth. To read article click here.

Protein Design Labs Inc. and Genentech Inc. form antigen alliance. To read article click here.

Sigma-Aldrich Corp. launches MISSION™ RNAi product line for R&D. To read article click here.

FDA grants orphan drug designation to Genelabs Technologies Inc.'s Prestara™ for the prevention of loss of bone mineral density. To read article click here.

-06/21/2005-

Press Release: Exeter Analytical has released a technical paper describing a technique for easy, direct automated elemental analysis of material retained on filter membranes used in water filtration and air monitoring applications. To read press release click here.

Press Release: Barnstead Genevac, leaders in solvent removal technology, has announced a new unique design of refrigerated solvent condenser for vacuum concentrators called the miVac Speed Trap. To read press release click here.

Lexicon Genetics Inc. and XOMA Ltd. form antibody collaboration. To read article click here.

Rosetta Genomics publishes in the journal Nature Genetics sudy identifies hundreds of novel human microRNAs. To read article click here.

-06/20/2005-

Press Release: For laboratories looking to safely and efficiently concentrate samples in 96- and/or 384-well microplates a range of affordable and high-speed evaporator systems is available from Porvair Sciences Ltd. To read press release click here.

Press Release: Guava Technologies Inc. has published a technical poster that describes and details results from a new live cell multi-parameter fluorescence assay that may be used to measure mitochondrial membrane potential and apoptosis. To read press release click here.

Press Release: ESA Biosciences has issued an application note that describes a methodology, based upon the company's CoulArray Electrochemical Array Detector technology, that is capable of quantifying the central level of a drug whilst simultaneously measuring its effect on central metabolism. To read press release click here.

Diversa Corp. and Merck & Co. Inc. extend collaboration on novel therapeutics antobodies. To read article click here.

MedImmune Inc. and Avalon Pharmaceuticals Inc. form small-molecule anti-inflamatory drug discovery collaboration. To read article click here.

-06/17/2005-

Provid Pharmaceuticals Inc. and Immune Control Inc. form drug discovery collaboration. To read article click here.

-06/16/2005-

Neurocrine Biosciences Inc. receives U.S. Patent No. 6903106 for novel polymorphic form of Indiplon for the treatment of insomnia. To read article click here.

Aldrich launches news Lithium Aminoborohydride (LAB) reagents for research. To read article click here.

Pfizer Inc. to acquire Vicuron Pharmaceuticals Inc. To read article click here.

-06/15/2005-

Chiron Corp. announces it will provide fewer vaccine shots in 2005 than anticipated. To read article click here.

Corixa Corp. rejects GlaxoSmithKline PLC takeover bid. To read article click here.

FDA approves Roche's Xeloda® (capecitabine) for post-surgery treatment of colon cancer. To read article click here.

-06/14/2005-

Press Release: INTEGRA Biosciences, market leader for laboratory equipment used in the sterilisation of microbiological media and production of agar plates, chose the recent ASM 2005 (American Society for Microbiology) meeting in Atlanta, USA to preview its new petri dish filler unit. To read press release click here.

FDA grants orphan drug designation to Vical Incorporated's vaccine against cytomegalovirus (CMV). To read article click here.

Medarex Inc. and Boehringer Ingelheim sign human therapeutic antibody development agreement. To read article click here.

Cephalon Inc. acquires Salmedix Inc. To read article click here.

Exelixis Inc. files investigational new drug (IND) application to the FDA for its Met and VEGFR2 (KDR) kinase inhibitor XL184 for cancer treatment. To read article click here.

-06/13/2005-

Press Release: Exhibiting at the recent Miptec 2005 conference, Porvair Sciences Ltd. - a leading supplier of applications focused microplate technology, presented its latest innovative products for high throughput screening and laboratory automation. To read press release click here.

Press Release: Guava Technologies, Inc. has introduced a new side scatter option for its Guava EasyCyte™ system that makes single-cell analysis with accurate cell enumeration more versatile and easier than ever before. To read press release click here.

Qiagen NV to acquire Tianwei Times. To read article click here.

Trimeris Inc. and ChemBridge Research Laboratories Inc. form small- molecule HIV drug discovery collaboration. To read article click here.

FDA approves Pfizer Inc.'s antibiotic Zmax™ (azithromycin extended release). To read article click here.

Cephalon Inc. acquires TRISENOX® from Cell Therapeutics Inc. for $70 million in cash. To read article click here.

-06/10/2005-

Vertex Pharmaceuticals Inc. initiates Phase II clinical trials of its oral p38 MAP kinase inhibitor VX-702 for rheumatoid arthritis treatment. To read article click here.

-06/09/2005-

Lorus Therapeutics Inc. receives European patent on its antisense drug GTI-2501. To read article click here.

-06/08/2005-

Press Release: Genevac, market leaders in solvent removal technology, have added to their range of sample holders, which enable simple and productive integration of their centrifugal evaporators with a wide array of HPLC fraction collector racks, synthesis reaction blocks and parallel chemistry glassware. To read press release click here.

ImClone Systems Inc.'s late-stage Erbitux study indicates this drug is effective in preventing the spread of head and neck cancer. To read article click here.

Surface Logix initiates Phase I clinical trials of novel PDE-5 inhibitor SLx-2101. To read article click here.

-06/07/2005-

Illumina Inc. launches two single nucleotide polymorphism (SNP) - based assay panels for genetic variation and function studies in the MHC region of the human genome. To read article click here.

TorreyPines Therapeutics files IND to the FDA for NGX267 for Alzheimer's Disease treatment. To read article click here.

-06/06/2005-

Press Release: Guava Technologies Inc. has introduced a new simple non-radioactive assay designed to improve the performance and sensitivity of cell proliferation assays compared to traditional population-based methods. To read press release click here.

Biotage AB acquires Argonaut Technologies. To read article click here.

Thermo Electron Corporation launches several new products, including its new hybrid mass spectrometer the LTQ Orbitrap™. To read article click here.

-06/03/2005-

Exelixis Inc. and Genentech form discovery collaboration on cancer, inflammatory diseases, and tissue growth and repair. To read article click here.

-06/02/2005-

Telik announces presentation at Pacific Growth Equities Life Sciences Growth Conference. To read article click here.

Biogen Idec Inc. and Elan report to FDA of another possible fatal brain disease associated to their multiple sclerosis drug Tysabri. To read article click here.

Anadys Pharmaceuticals Inc. and Novartis AG sign agreement to develop Anadys' oral hepatitis drug ANA975. To read article click here.

Chiron Corporation and the Multiple Myeloma Research Consortium initiate Phase I linical trials of CHIR-258 for multiple myeloma treatment. To read article click here.

XenoPort Inc. goes public. To read article click here.

-06/01/2005-

Press Release: The GreenHouse Plus Parallel Synthesizer from Radleys Discovery Technologies brings all the benefits of parallel synthesis productivity to organic chemists at a fraction of the cost of automated systems. To read press release click here.

Bristol-Myers Squibb Co. to pay $89 million to settle lawsuits. To read article click here.

Argonaut Technologies' stockholders approve sale of chemistry consumables business and other assets to Biotage AB. To read article click here.

Immunomedics Inc. initiates Phase III clinical trials of Epratuzumab for lupus treatment. To read article click here.

TransMolecular Inc. initates Phase II clinical trials of 131I-TM-601 for recurrent high-grade glioma. To read article click here.